Side-by-side financials for ELUT and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ELUT | RVMD |
|---|---|---|
| Market cap | - | $32.71 B |
| US-listed rank | - | #439 |
| Revenue (latest FY) | $12.29M | $0.00 |
| Net income (latest FY) | $53.38M | -$1.13B |
| Net margin | 434.2% | - |
| SEC filings | 348 | 782 |
In their latest fiscal years, ELUTIA INC. reported $12.29M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: ELUTIA INC. and Revolution Medicines, Inc., or browse the full rankings.